With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...

A new study led by researchers from Boston University Chobanian & Avedisian School of Medicine has found there is no consensus in how clinical experts interpret CGM reports from people without ...

DexCom , Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) systems for diabetes management with a market capitalization of $34.8 billion, finds itself at a critical juncture as it ...

Exercise is essential for managing diabetes and reducing the risk of heart disease. Regular physical activity helps combat ...

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

Circadian Health, a pioneering leader in virtual-first specialty care, has been named a Winner in the 2025 HLTH Foundation's 2nd Annual Techquity for Health Case Study Awards for its work in ...

Allspring Global Investments Holdings LLC grew its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 28.8% in ...

By Phil Galewitz for KFF Health News. Broadcast version by Trimmel Gomes for Florida News Connection reporting for the KFF Health News-Public News Service Collaboration Just a few years ago, children ...

The results have been transformative, with several cases of women completely reversing their diabetes for at least 12 months.

Stock analysts at Leerink Partnrs increased their Q1 2025 earnings per share estimates for DexCom in a research report issued ...